Assistant Attending
Memorial Sloan Kettering Cancer Center
Dr. Bartlett is a surgical oncologist at Memorial Sloan Kettering Cancer Center. His clinical practice focuses on the treatment of patients with melanoma and sarcoma. He is a clinical and translational surgeon-scientist with ongoing trials broadly aimed at improving the sensitivity of immunotherapeutics for patients with sarcoma. Ongoing current trials include as the Co-PI on a trial combining PD-1 and adenosine receptor inhibition for patients with dedifferentiated liposarcoma, the PI on an ongoing trial combining pembrolizumab and isolated limb infusion of melphalan and dactinomycin for patients with extremity sarcoma (NCT04332874), and as the PI on the currently presented trial exploring the early efficacy of intratumorally-injected tigilanol tiglate in patients with soft tissue sarcoma (NCT05755113).
